Concerning the reports of sleep disorders, it is of utmost importance to note that sleep abnormalities are often not evaluated by the treating physician at initial presentation, which could result in an insufficient recognition of this characteristic feature in anti‐IgLON5 disease. This evidence concerns the gene IGLON5 and sleep disorder.